Fidelity Investments’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$377M Buy
17,740,972
+5,823,490
+49% +$116M 0.02% 617
2025
Q4
$194M Buy
11,917,482
+3,459,481
+41% +$52.3M 0.01% 876
2025
Q3
$98.9M Sell
8,458,001
-538,403
-6% -$7.02M 0.01% 1187
2025
Q2
$104M Sell
8,996,404
-896,735
-9% -$8.17M 0.01% 1102
2025
Q1
$86.4M Sell
9,893,139
-3,561,295
-26% -$44.9M 0.01% 1151
2024
Q4
$193M Buy
13,454,434
+86,455
+0.6% +$1.36M 0.01% 838
2024
Q3
$302M Buy
13,367,979
+357,470
+3% +$7.39M 0.02% 664
2024
Q2
$253M Buy
13,010,509
+81,260
+0.6% +$2.13M 0.02% 702
2024
Q1
$485M Buy
12,929,249
+143,713
+1% +$6.31M 0.03% 465
2023
Q4
$715M Buy
12,785,536
+118,538
+0.9% +$5.16M 0.06% 314
2023
Q3
$523M Buy
12,666,998
+4,565,400
+56% +$237M 0.05% 372
2023
Q2
$452M Buy
8,101,598
+3,729,304
+85% +$202M 0.04% 446
2023
Q1
$244M Buy
4,372,294
+1,169,928
+37% +$54.6M 0.02% 633
2022
Q4
$117M Sell
3,202,366
-509,836
-14% -$16.7M 0.01% 911
2022
Q3
$106M Sell
3,712,202
-2,483,325
-40% -$94.6M 0.01% 936
2022
Q2
$280M Buy
6,195,527
+2,070,318
+50% +$107M 0.03% 582
2022
Q1
$314M Sell
4,125,209
-3,062,865
-43% -$268M 0.03% 614
2021
Q4
$1.07B Sell
7,188,074
-1,177,765
-14% -$180M 0.08% 225
2021
Q3
$1.22B Buy
8,365,839
+467,613
+6% +$80.3M 0.1% 173
2021
Q2
$1.55B Sell
7,898,226
-1,843,937
-19% -$334M 0.12% 139
2021
Q1
$1.76B Sell
9,742,163
-328,920
-3% -$56.8M 0.15% 118
2020
Q4
$1.43B Buy
10,071,083
+1,484,389
+17% +$215M 0.13% 143
2020
Q3
$1.07B Buy
8,586,694
+1,398,273
+19% +$147M 0.11% 167
2020
Q2
$642M Buy
7,188,421
+3,996,052
+125% +$311M 0.07% 244
2020
Q1
$199M Buy
3,192,369
+57,291
+2% +$4.47M 0.03% 505
2019
Q4
$239M Buy
3,135,078
+385,217
+14% +$23.2M 0.03% 583
2019
Q3
$139M Buy
+2,749,861
New +$152M 0.02% 758

Other funds holding TXG